Table 1. Baseline characteristics of 81 patients.
| mean ± standard deviation / n (%) | |
|---|---|
| Age, years | 44.8 ± 12.3 |
| Male gender | 43(53.1) |
| Type of adenoma | |
| Gonadotropin | 18 (22.2) |
| Prolactin | 18 (22.2) |
| Null-cell | 21 (25.9) |
| Others1 | 24 (29.6) |
| NFPA adenoma | 47 (58.0) |
| GnH | 18 (38.3) |
| PRL | 2 (4.3) |
| Others | 6 (12.8) |
| Null cell | 21 (44.7) |
| Maximum diameter of pituitary adenoma, mm | 2.3 ± 0.8 |
| < 10 | 4 (4.9) |
| 10-40 | 72 (88.9) |
| ≥ 40 | 5 (6.2) |
| Tumor volume, cm3 | 61.8 ± 59.3 |
| Level of tumor resection | |
| Complete | 47 (58.0) |
| Massive | 23 (28.4) |
| Partial | 11 (13.6) |
| Grade of cavernous sinus invasion | 2.1 ± 0.9 |
| Grade of suprasellar extension | 2.5 ± 1.0 |
| Total score of invasion | 6.5 ± 2.1 |
| Cystic degeneration | 34 (42.0) |
Abbreviations: NFPA: non-functioning pituitary adenomas
1 Other types of adenoma include growth hormone (GH), adrenocorticotropic hormone ACTH), thyroid-stimulating hormone (TSH), and plurihormonal pituitary type